TERMINATION AGREEMENT
Exhibit 10.2
THIS TERMINATION AGREEMENT is effective as of June 1, 2010 (the “Effective Date”)
between MEDIMMUNE, LLC., a limited liability corporation organized and existing under the laws of
Delaware (“MEDIMMUNE”) and CORNERSTONE THERAPEUTICS INC., a corporation organized and existing
under the laws of Delaware (“CTI”).
NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein
contained, the Parties hereby agree as follows:
As of the Effective Date, CTI and MEDIMMUNE hereby terminate the Exclusive License and
Collaboration Agreement effective as of July 30, 2003 by and between MEDIMMUNE and CTI, and any
amendments made thereto, and the rights and licenses granted thereunder and any and all rights and
obligations thereunder, including those incurred prior to, as of or subsequent to the Effective
Date, and no rights or obligations of the Exclusive License and Collaboration Agreement will
survive such termination, including but not limited to the obligations of Section 10.4 of the
Exclusive License and Collaboration Agreement notwithstanding anything in the Exclusive License and
Collaboration Agreement to the contrary
IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date(s) set forth
below.
| MEDIMMUNE, LLC. | Cornerstone Therapeutics Inc. | ||||
| BY: | /s/ Sun Park | BY: | /s/ Xxxxxx Xxxxxx | ||
TITLE:
VP, Business Development |
TITLE: Secretary | ||||
DATE: 6/21/10 |
DATE: 6/29/10 | ||||
